Stockreport

Revance down 10% premarket on pricing equity offering [Seeking Alpha]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF Revance down 10% premarket on pricing equity offering Revance Therapeutics (NASDAQ: RVNC priced Underwriters' over-allotment is an additional 975,000 shares. Net proceed [Read more]